We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026
20 Aug 2026 - 22 Aug 2026

Trial Begins on Novel Stroke Therapy

By HospiMedica staff writers
Posted on 19 Feb 2001
Preclinical studies have shown that treatment with an oxygenated fluorocarbon nutrient emulsion (OFNE) several hours after initiation of a severe ischemic stroke can limit brain damage. More...
A phase I safety trial is now under way.

The OFNE, called Revoxyn, bypasses the blocked blood vessels and delivers oxygen and nutrients directly to the injured brain tissue, says the developer, Neuron Therapeutics, Inc. (Malvern, PA, USA). In the brain, Revoxyn acts to reduce the amount of swelling and damage to brain tissue caused by a sudden interruption in blood flow. The first person to receive this investigational therapy was recently treated at Thomas Jefferson University Hospital (Philadelphia, PA, USA). The novel drug and its delivery system are the outgrowth of research at Thomas Jefferson University.

"Stroke treatment represents an enormous unmet medical need,” said Dr. Rodney Bell, principal investigator and director of the Jefferson Stroke Center. "The approach Neuron Therapeutics is taking is remarkably different from anything that has been tried before in

that it involves direct delivery of oxygen and nutrients to oxygen-starved brain tissue.”



Related Links:
Neuron Therapeutics

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Digital Radiography System (Ceiling Free)
Digix CF Series
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.